Liver

Immunotherapy in HCC: Navigating Combinations, Patient Selection, and Evolving Opportunities
Dr. He shares her insights on the evolving role of single-agent vs combination IO in the neoadjuvant setting for aHCC.
Advertisement
Advertisement